Santhera Pharmaceuticals Holding AG (SPHDF)
Santhera Pharmaceuticals Market Cap : 274.57M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 274.57M |
| October 22, 2026 | 274.57M |
| October 21, 2026 | 274.57M |
| October 20, 2026 | 274.57M |
| October 19, 2026 | 274.57M |
| October 16, 2026 | 274.57M |
| October 15, 2026 | 274.57M |
| October 14, 2026 | 274.57M |
| October 13, 2026 | 274.57M |
| October 12, 2026 | 274.57M |
| October 09, 2026 | 274.57M |
| October 08, 2026 | 274.57M |
| October 07, 2026 | 274.57M |
| October 06, 2026 | 274.57M |
| October 05, 2026 | 274.57M |
| October 02, 2026 | 274.57M |
| October 01, 2026 | 274.57M |
| September 30, 2026 | 274.57M |
| September 29, 2026 | 296.92M |
| September 28, 2026 | 296.92M |
| September 25, 2026 | 265.06M |
| September 24, 2026 | 265.06M |
| September 23, 2026 | 265.06M |
| September 22, 2026 | 265.06M |
| September 21, 2026 | 265.06M |
| Date | Value |
|---|---|
| September 18, 2026 | 265.06M |
| September 17, 2026 | 265.06M |
| September 16, 2026 | 265.06M |
| September 15, 2026 | 265.06M |
| September 14, 2026 | 265.06M |
| September 11, 2026 | 265.06M |
| September 10, 2026 | 265.06M |
| September 09, 2026 | 265.06M |
| September 08, 2026 | 265.06M |
| September 04, 2026 | 311.40M |
| September 03, 2026 | 311.40M |
| September 02, 2026 | 311.40M |
| September 01, 2026 | 311.40M |
| August 31, 2026 | 311.40M |
| August 28, 2026 | 311.40M |
| August 27, 2026 | 311.40M |
| August 26, 2026 | 311.40M |
| August 25, 2026 | 311.40M |
| August 24, 2026 | 311.40M |
| August 21, 2026 | 311.40M |
| August 20, 2026 | 311.40M |
| August 19, 2026 | 311.40M |
| August 18, 2026 | 311.40M |
| August 17, 2026 | 311.40M |
| August 14, 2026 | 311.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 945.73M |
| BeOne Medicines Ltd. | 39.34B |
| AC Immune SA | 220.46M |
| CRISPR Therapeutics AG | 4.774B |
| Idorsia Ltd. | 1.415B |
Market Cap Related Metrics
| PS Ratio | 1.983 |
| Price | 18.30 |
| Earnings Yield | -15.74% |